BluDerma
Juvelook

VAIM

Juvelook

Brand

VAIM

Category

Biostimulator (PLLA/PCL)

Origin

Korea

Options

50 mg · Volume 200 mg

Available options

50 mgVolume 200 mg

Interested in ordering Juvelook? Send an enquiry and our team will follow up with availability and pricing.

Overview

Juvelook is a PDLLA plus hyaluronic acid hybrid skin booster from Korean manufacturer VAIM, approved by Korea's MFDS and CE-marked. It pairs poly-D,L-lactic acid microparticles with non-crosslinked HA to combine immediate hydration with progressive collagen stimulation. It is positioned for skin-quality, texture and fine-line rejuvenation rather than discrete volumisation.

How it works

PDLLA porous microparticles sit in the dermis and act as a scaffold, stimulating fibroblasts to generate new collagen and elastin over the weeks following treatment. The co-formulated non-crosslinked hyaluronic acid provides immediate hydration and a light plumping effect while the collagen response develops; the PDLLA gradually resorbs while the new collagen persists.

Indications

  • Fine lines and crepey skin
  • Skin texture and elasticity decline
  • Superficial dermal rejuvenation and skin quality
  • Overall facial rejuvenation and collagen loss

Key features

  • Hybrid PDLLA plus non-crosslinked HA formulation
  • Immediate hydration combined with progressive collagen and elastin stimulation
  • MFDS-approved and CE-marked
  • Porous PDLLA microparticle scaffold
  • Lyophilised vial for on-site reconstitution

Benefits

  • Combines early radiance with long-term collagen remodelling in one product
  • Well-suited to skin-quality and fine-line indications for a broad patient base
  • Recognised regulatory clearances support clinic confidence and marketing
  • Established Korean manufacturer with wide international distribution

Composition

PDLLA (poly-D,L-lactic acid) approximately 42.4 mg plus non-crosslinked hyaluronic acid approximately 7.5 mg per lyophilised vial.

Usage & handling

Supplied as lyophilised powder requiring reconstitution and hydration per the treating physician's technique before injection into the superficial-to-mid dermis. Immediate hydration is followed by collagen-driven improvement that builds over the following weeks; space repeat sessions for cumulative skin-quality gains.

For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.